Rebecca Loomis

Title: Innovations by Rebecca Loomis in Antigen Delivery Platforms

Introduction

Rebecca Loomis is an accomplished inventor based in Philadelphia, PA (US). She has made significant contributions to the field of vaccine development through her innovative work on antigen delivery platforms. With a total of 2 patents to her name, her inventions focus on enhancing immune responses against herpes virus proteins.

Latest Patents

Rebecca's latest patents revolve around antigen delivery platforms designed for the effective delivery of herpes virus proteins to cells. These inventions detail how proteins that form complexes in vivo can elicit potent neutralizing antibodies. By utilizing these platforms, the presentation of herpes virus proteins can generate broad and potent immune responses, which are crucial for vaccine development.

Career Highlights

Rebecca Loomis is currently associated with GlaxoSmithKline Biologicals SA, where she continues to advance her research and innovations. Her work has been pivotal in the development of new strategies for vaccine delivery, showcasing her expertise in the field.

Collaborations

Some of her notable coworkers include Michael Franti and Anders Lilja, who contribute to her research endeavors and collaborative projects.

Conclusion

Rebecca Loomis stands out as a key innovator in the realm of antigen delivery systems, making strides that could significantly impact vaccine development. Her work exemplifies the importance of innovation in addressing public health challenges.